The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities
18 juli 2026 uppdaterad av: Woosang Hwang, Sookmyung Women's University
The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities: A Randomized Controlled Trial Study
The aim of this study is to investigate whether a smartphone-based Acceptance and Commitment Therapy (ACT) program can improve the mental health and quality of life of care workers in long-term care facilities. The research question of this study is as follows: Among caregivers working in long-term care facilities, are there differences in mental health, quality of life, and job burnout between the experimental group that participated in a smartphone-based ACT program and the control group that participated in a document-based ACT program?
Participants in the experimental group will complete 70 daily sessions of a smartphone-based ACT program using Anzeilax-Plus, administered Monday through Friday over a 14-week period. Participants in the control group will complete 70 daily assignments from a document-based ACT program, administered Monday through Friday over the same 14-week period.
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Studietyp
Interventionell
Inskrivning (Beräknad)
140
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Woosang Hwang, Ph.D.
- Telefonnummer: 82-2-2077-7380
- E-post: woosanghwang@sookmyung.ac.kr
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Ja
Beskrivning
Inclusion Criteria:
- Caregivers aged 18 years or older who provide care services to older adults in long-term care facilities, own a smartphone, and have no history of depression or other mental illnesses.
Exclusion Criteria:
- Caregivers with a history of depression or other mental illnesses, or those who do not own a smartphone.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Mobile-based ACT group
One daily session of the smartphone-based ACT program delivered through the Anzeilax-Plus app
|
Participants will complete a daily Acceptance and Commitment Therapy (ACT) session through a mobile application on their smartphones.
|
|
Aktiv komparator: Document-based ACT group
One daily session of the document-based ACT program
|
Participants will complete a daily Acceptance and Commitment Therapy (ACT) session using materials provided by the research team.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Depressive symptoms
Tidsram: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Depressive symptoms will be measured using the Patient Health Questionnaire-9, a 9-item self-report measure.
Each item is rated on a 4-point scale, with total scores ranging from 9 to 36.
Higher scores indicate higher levels of depressive symptoms.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Anxiety
Tidsram: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Anxiety will be measured using the Generalized Anxiety Disorder-7, a 7-item self-report measure.
Each item is rated on a 4-point scale, with total scores ranging from 7 to 28.
Higher scores indicate higher levels of anxiety.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Stress
Tidsram: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Stress will be measured using the Perceived Stress Scale-10, a 10-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 10 to 50.
Higher scores indicate higher levels of stress.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Self-esteem
Tidsram: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Self-esteem will be measured using the Rosenberg Self-Esteem Scale, a 10-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 10 to 50.
Higher scores indicate higher levels of self-esteem
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Job burnout
Tidsram: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Job burnout will be measured using the Maslach Burnout Inventory-General Survey, a 15-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 15 to 75.
Higher scores indicate higher levels of job burnout.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
|
Quality of life (Psychological and physical well-being)
Tidsram: From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Quality of life will be measured using the World Health Organization Quality of Life Scale a 15-item self-report measure.
Each item is rated on a 5-point scale, with total scores ranging from 15 to 75.
Higher scores indicate higher levels of quality of life.
|
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
27 juli 2026
Primärt slutförande (Beräknad)
31 december 2026
Avslutad studie (Beräknad)
28 februari 2027
Studieregistreringsdatum
Först inskickad
15 juli 2026
Först inskickad som uppfyllde QC-kriterierna
15 juli 2026
Första postat (Faktisk)
20 juli 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
21 juli 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
18 juli 2026
Senast verifierad
1 juli 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- SMWU-2604-HR-020-01
- RS-2026-25477485 (Annat bidrag/finansieringsnummer: National Research Foundation of Korea)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .